Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
The Journal of Thoracic and Cardiovascular Surgery|November 24, 2024
Esophagectomy may have a role in stage IV esophageal adenocarcinomaMarisa Sewell, Nicolas Toumbacaris, Kay See Tan, et al.
Journal of Clinical Medicine|May 11, 2024
Salvage Ablative Radiotherapy for Isolated Local Recurrence of Pancreatic Adenocarcinoma following Definitive SurgeryEdward Christopher Dee, Victor C Ng, Eileen M O'Reilly, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2023
Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation TrialAndreas Rimner, Daphna Y Gelblum, Abraham J Wu, et al.
Practical Radiation Oncology|June 16, 2026
Prophylactic versus therapeutic sucralfate in patients at high risk for radiation esophagitis: randomized controlled trialJacob Y Shin, Melissa Assel, Abraham J Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2025
Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric CancerHenry S Walch, Raktim Borpatragohain, Justin Jee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2021
Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and PathwaysSmita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2026
Impact of KRAS Mutations and Co-Alterations on Outcomes in Stage III Non-Squamous Non-Small Cell Lung Cancer Treated with Chemoradiation and ImmunotherapyNikhil P Mankuzhy, Valentina Santo, Jacob Y Shin, et al.
JAMA Oncology|March 23, 2018
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal CancerAndrea Cercek, Campbell S D Roxburgh, Paul Strombom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional AnalysisWilliam J Magnuson, Nataniel H Lester-Coll, Abraham J Wu, et al.
Pageof 15